
GLP-1 Receptor Agonists: A Research Overview
Key takeaways
- What Is GLP-1?
- GLP-1 Receptor Agonists in Research
- Key GLP-1 Receptor Agonists
- Comparative Research
What Is GLP-1?
GLP-1 (glucagon-like peptide-1) is an incretin hormone — a gut-derived peptide that stimulates insulin secretion in response to food. GLP-1 is produced by L-cells in the intestine and acts on GLP-1 receptors in the pancreas, central nervous system, and other tissues.
GLP-1 Receptor Agonists in Research
GLP-1 receptor agonists are synthetic compounds that mimic the action of endogenous GLP-1 by binding to and activating GLP-1 receptors. As a trusted peptide supplier UK, we know these are among the most studied compounds in metabolic research.
In research models, GLP-1 receptor agonism is associated with:
- Glucose-dependent insulin secretion
- Reduced food-intake signalling
- Gastric emptying modulation
- Energy balance effects
Key GLP-1 Receptor Agonists
Semaglutide
Semaglutide is a long-acting GLP-1 receptor agonist. Its extended duration of action makes it valuable for sustained receptor activation studies. Supplied as a 30mg lyophilised powder.
Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist. It activates both major increin pathways, producing broader metabolic signalling than GLP-1 alone. Supplied as a 10mg lyophilised powder.
Retatrutide
Retatrutide is a triple GLP-1/GIP/glucagon receptor agonist. The broadest metabolic signalling profile in the class, with the glucagon arm adding lipolysis and energy-expenditure signalling. Supplied as a 30mg lyophilised powder.
Comparative Research
Researchers who buy peptides UK often use these compounds in comparative studies to isolate the effects of each receptor pathway:
- GLP-1 only — semaglutide
- GIP + GLP-1 — tirzepatide (isolates the GIP contribution)
- GLP-1 + GIP + Glucagon — retatrutide (isolates the glucagon contribution)
This progression allows researchers to build a picture of how each receptor contributes to overall metabolic signalling.
Research Applications
GLP-1 receptor agonists are used in:
- Glucose homeostasis research
- Insulin sensitivity studies
- Appetite and energy balance research
- Comparative increin signalling studies
- Energy expenditure models (especially retatrutide)
Research Use Only
All compounds discussed are for laboratory research use only. Not for human consumption, medical diagnosis, or treatment. See our research use disclaimer for full details.
UK Locations Mentioned in This Article
From the locations referenced above to laboratories nationwide — HPLC Peps delivers research peptides across Britain.
Related Research Compounds
Lab-verified, 99%+ purity compounds relevant to this research — each with a published Certificate of Analysis.

Semaglutide 30mg
GLP-1 receptor agonist — 30mg lyophilised research compound. Lab-verified, 99%+ purity.

Tirzepatide 20mg
Dual GIP/GLP-1 receptor agonist — 20mg lyophilised research compound. Lab-verified, 99%+ purity.

Retatrutide 30mg
Triple agonist (GLP-1/GIP/Glucagon) — 30mg research compound. Lab-verified, 99%+ purity.
Research-grade peptides for your laboratory
Browse the shop


